The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
N-Heterocyclic carbene metal complexes in medicinal chemistry
Abstract
Metal complexes with N-heterocyclic carbene (NHC) ligands are widely used in chemistry due to their catalytic properties and applied for olefin metathesis among other reactions. The enhanced application of this type of organometallics has over the last few years also triggered a steadily increasing number of studies in the fields of medicinal chemistry, which take advantage of the fascinating chemical properties of these complexes. In fact it has been demonstrated that metal NHC complexes can be used to develop highly efficient metal based drugs with possible applications in the treatment of cancer or infectious diseases. Complexes of silver and gold have been biologically evaluated most frequently but also platinum or other transition metals have demonstrated promising biological properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steric effects of phosphorus ligands in organometallic chemistry and homogeneous catalysis
Tolman, C. A. (1977) · Chemical Reviews · doi:10.1021/cr60307a002 · Cited by 4,824
Arduengo, A. J., Harlow, R. L., & Kline, M. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00001a054 · Cited by 4,228
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Self-citationIonic liquids are not always green: hydrolysis of 1-butyl-3-methylimidazolium hexafluorophosphate
Swatloski, R. P., Holbrey, J. D., & Rogers, R. D. (2003) · Green Chemistry · doi:10.1039/b304400a · Cited by 982
1,3-Dimethyl-4-imidazolinyliden-(2)-pentacarbonylchrom ein neuer übergangsmetall-carben-komplex
Öfele, K. (1968) · Journal of Organometallic Chemistry · doi:10.1016/s0022-328x(00)88691-x · Cited by 878
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
Self-citationFocus on mammalian thioredoxin reductases — Important selenoproteins with versatile functions
Arnér, E. S. J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.01.014 · Cited by 673
Ray, S., Mohan, R., Singh, J. K., Samantaray, M. K., Shaikh, M. M., Panda, D., & Ghosh, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075889z · Cited by 656
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
Holmgren, A., & Lu, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.083 · Cited by 574
Melaiye, A., Sun, Z., Hindi, K., Milsted, A., Ely, D., Reneker, D. H., Tessier, C. A., & Youngs, W. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja040226s · Cited by 557
Rhodium and Iridium Complexes of N-Heterocyclic Carbenes via Transmetalation: Structure and Dynamics
Chianese, A. R., Li, X., Janzen, M. C., Faller, J. W., & Crabtree, R. H. (2003) · Organometallics · doi:10.1021/om021029+ · Cited by 516
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Nobili, S., Mini, E., Landini, I., Gabbiani, C., Casini, A., & Messori, L. (2010) · Medicinal Research Reviews · doi:10.1002/med.20168 · Cited by 503
Gold compounds as therapeutic agents for human diseases
Berners-Price, S. J., & Filipovska, A. (2011) · Metallomics · doi:10.1039/c1mt00062d · Cited by 495
Role of membrane potential in the regulation of cell proliferation and differentiation
Sundelacruz, S., Levin, M., & Kaplan, D. L. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9080-2 · Cited by 489
N-Heterocyclic carbene–silver complexes: A new class of antibiotics
Kascatan-Nebioglu, A., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.08.019 · Cited by 479
Steric and electronic effects in the bonding of N-heterocyclic ligands to transition metals
Cavallo, L., Correa, A., Costabile, C., & Jacobsen, H. (2005) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2005.07.012 · Cited by 479
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Bergamo, A., & Sava, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01816c · Cited by 440
Targeting the mitochondrial cell death pathway with gold compounds
Barnard, P. J., & Berners-Price, S. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.04.006 · Cited by 417
Metal-NHC complexes: a survey of anti-cancer properties
Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., et al. (2009) · Dalton Transactions · doi:10.1039/b906308k · Cited by 384
Electronic and Steric Parameters of 76 N-Heterocyclic Carbenes in Ni(CO)3(NHC)
Gusev, D. G. (2009) · Organometallics · doi:10.1021/om900654g · Cited by 379
Designing organometallic compounds for catalysis and therapy
Noffke, A. L., Habtemariam, A., Pizarro, A. M., & Sadler, P. J. (2012) · Chemical Communications · doi:10.1039/c2cc30678f · Cited by 370
Formation of Water-Soluble Pincer Silver(I)−Carbene Complexes: A Novel Antimicrobial Agent
Melaiye, A., Simons, R. S., Milsted, A., Pingitore, F., Wesdemiotis, C., Tessier, C. A., & Youngs, W. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030262m · Cited by 349
On the potential of thioredoxin reductase inhibitors for cancer therapy
Urig, S., & Becker, K. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.004 · Cited by 337
Chianese, A. R., Kovacevic, A., Zeglis, B. M., Faller, J. W., & Crabtree, R. H. (2004) · Organometallics · doi:10.1021/om049903h · Cited by 329
Barnard, P. J., Wedlock, L. E., Baker, M. V., Berners‐Price, S. J., Joyce, D. A., Skelton, B. W., & Steer, J. H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601526 · Cited by 260
Schuh, E., Pflüger, C., Citta, A., Folda, A., Rigobello, M. P., Bindoli, A., Casini, A., & Mohr, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300428v · Cited by 246
Hindi, K. M., Siciliano, T. J., Durmus, S., Panzner, M. J., Medvetz, D. A., Reddy, D. V., Hogue, L. A., Hovis, C. E., Hilliard, J. K., Mallet, R. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0708679 · Cited by 218
Organometallic Compounds: An Opportunity for Chemical Biology?
Patra, M., & Gasser, G. (2012) · ChemBioChem · doi:10.1002/cbic.201200159 · Cited by 213
Wai-Yin Sun, R., Lok-Fung Chow, A., Li, X.-H., Yan, J. J., Sin-Yin Chui, S., & Che, C.-M. (2011) · Chemical Science · doi:10.1039/c0sc00593b · Cited by 181
Cyclometalated gold(iii) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons
Yan, J. J., Chow, A. L.-F., Leung, C.-H., Sun, R. W.-Y., Ma, D.-L., & Che, C.-M. (2010) · Chemical Communications · doi:10.1039/c001216e · Cited by 179
Hindi, K. M., Ditto, A. J., Panzner, M. J., Medvetz, D. A., Han, D. S., Hovis, C. E., Hilliard, J. K., Taylor, J. B., Yun, Y. H., Cannon, C. L., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.044 · Cited by 169
Leid, J. G., Ditto, A. J., Knapp, A., Shah, P. N., Wright, B. D., Blust, R., Christensen, L., Clemons, C. B., Wilber, J. P., Young, G. W., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr408 · Cited by 167
Synthesis of a reverse ylide from a nucleophilic carbene
Arduengo, A. J., Kline, M., Calabrese, J. C., & Davidson, F. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00025a063 · Cited by 160
Wang, C., Shih, W., Chang, H. C., Kuo, Y., Hung, W., Ong, T., & Li, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101096x · Cited by 143
Eloy, L., Jarrousse, A., Teyssot, M., Gautier, A., Morel, L., Jolivalt, C., Cresteil, T., & Roland, S. (2012) · ChemMedChem · doi:10.1002/cmdc.201200055 · Cited by 139
Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study
Krishnamurthy, D., Karver, M. R., Fiorillo, E., Orrù, V., Stanford, S. M., Bottini, N., & Barrios, A. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800101w · Cited by 127
Rackham, O., Shearwood, A.-M. J., Thyer, R. T., McNamara, E. L., Davies, S. M. K., Callus, B. A., Miranda‐Vizuete, A., Berners‐Price, S. J., Cheng, Q., Arnér, E. S. J., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.015 · Cited by 126
Youngs, W. J., Knapp, A. R., Wagers, P. O., & Tessier, C. A. (2011) · Dalton Transactions · doi:10.1039/c1dt11100k · Cited by 112
Sivaram, H., Tan, J., & Huynh, H. V. (2012) · Organometallics · doi:10.1021/om300444c · Cited by 106
Köster, S. D., Alborzinia, H., Can, S., Kitanović, I., Wölfl, S., Rubbiani, R., Ott, I., Riesterer, P., Prokop, A., Merz, K., et al. (2012) · Chemical Science · doi:10.1039/c2sc01127a · Cited by 105
Self-citationCytotoxicity of Gold(I) N‐Heterocyclic Carbene Complexes Assessed by Using Human Tumor Cell Lines
Weaver, J., Gaillard, S., Toye, C., Macpherson, S., Nolan, S. P., & Riches, A. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201100321 · Cited by 98
Jellicoe, M. M., Nichols, S. J., Callus, B. A., Baker, M. V., Barnard, P. J., Berners‐Price, S. J., Whelan, J., Yeoh, G. C., & Filipovska, A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn093 · Cited by 75
Design of nickel chelates of tetradentate N-heterocyclic carbenes with subdued cytotoxicity
Ray, S., Asthana, J., Tanski, J. M., Shaikh, M. M., Panda, D., & Ghosh, P. (2009) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2009.03.036 · Cited by 61
Cited by
Chemical biology of anticancer gold(iii) and gold(i) complexes
Zou, T., Lum, C. T., Lok, C.-N., Zhang, J.-J., & Che, C.-M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00132c · Cited by 628
Ferrocifen type anti cancer drugs
Jaouen, G., Vessières, A., & Top, S. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00486a · Cited by 581
Bertrand, B., & Casini, A. (2014) · Dalton Trans. · doi:10.1039/c3dt52524d · Cited by 441
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Zhukhovitskiy, A. V., MacLeod, M. J., & Johnson, J. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00220 · Cited by 363
Metadata
- Authors
- Oehninger, L., Rubbiani, R., & Ott, I.
- Venue
- Dalton Trans.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 42
- Issue
- 10
- Pages
- 3269-3284
- ISSN
- 1477-9226 (ISSN-L)
- 1477-9234
- OpenAlex
- W2003519579
- Cited by
- 560
- References
- 44
- FWCI
- 20.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.